MEDI NORWAY AS

Org. no. 968259733 · KARMØY · Founded 1993 · 17 employees

Score · fiscal year 2024

57of 100

How to read this: the company is ahead of 63 % of small companies in the same sector in 2024. What does this mean?

Rank: 10,619 of 28,783 · Handel

Profile

Cheetah · Sprinter

High profitability, lower solidity

Position against comparable companies in 2024, not a verdict on the company. Based on profitability 76 and solidity 36 out of 100 among small companies in the same sector in 2024. Methodology

Against the sector

MEDI NORWAY AS is 7 points above the median for small companies in the same sector in 2024.

Median score 50 among 26,966 companies.

Against small companies in the same sector in 2024: operating margin 7.7% (median 2.1%) and equity ratio 27.4% (median 35.5%).

Source: Register of Company Accounts and Central Coordinating RegisterFetched 28 October 2026Report an issue
Key figures · 2024

The numbers behind the score

The numbers behind the score · 2024
MeasureCompanyMedianAhead of
Operating revenue55 MNOK3 MNOK
Operating margin 7.7% 2.1% 72 %
Profit margin 7.7% 1.8% shown, not part of the index
Return on assets 19.2% 2.9% 79 %
Equity ratio 27.4% 35.5% 44 %
Debt-to-equity 2.64 1.03 29 %
Current ratio 1.34 1.62 41 %
Revenue growth 14.8% 2.6% 70 %
Revenue per employee3.23 MNOK1.54 MNOK

The median and “ahead of” refer to small companies in the same sector in 2024. The bar shows the share of companies the figure is ahead of.

With an index of 57, MEDI NORWAY AS does better than 63% of small companies in the same sector (27,072 companies) in 2024.

Over time

Score 2023–2025

CompanyMedian0255075100202320242025
  • MEDI NORWAY AS
  • Median: small companies in the same sector
Analysis · 2024

What the numbers say

MEDI NORWAY AS had an operating margin of 7.7% and an equity ratio of 27.4% in 2024, and ranks 10,619 of 28,783 in Handel.

From 2023 to 2024: the equity ratio fell from 40.2% to 27.4% and revenue grew by 15%.

This text is generated automatically from the 2024 accounts.

Estimated value · 2024

Three simple methods

The methods give between 6 MNOK and 45 MNOK.

MethodInputMultipleEstimate
P/E Net profit: 3.3 MNOK 10.0 33 MNOK
EV/EBIT Operating profit: 4.2 MNOK
minus net debt −10.8 MNOK
8.0 45 MNOK
P/B Equity: 6.3 MNOK 1.0 6 MNOK

A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation

Indications · 2024

Worth a closer look

No rules were triggered for this year.

Indications based on the latest annual accounts from open data. Not investment or financial advice.

Data quality

No anomalies found in the figures.

Stress test · 2017

Scenario analysis: the sector's weakest year

We have no accounts for 2017, the sector's weakest year, for this company.

The sector's weakest year was 2017, with a median operating margin of −134.9%. Based on the 10 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology

Components · 2024

What the score is made of

Profitability76 weight 30%
Solidity36 weight 25%
Liquidity41 weight 15%
Growth70 weight 15%
Consistency54 weight 15%

Durability: 59 (average over 2 years)

Index version 2. Data completeness 100%: the share of the weights that had data.

2024

Questions and answers

How profitable is MEDI NORWAY AS?

The operating margin was 7.7% in 2024, against a median of 2.1% among small companies in the same sector. Return on assets was 19.2%.

How solid is MEDI NORWAY AS?

The equity ratio was 27.4% in 2024 (median 35.5%). Debt-to-equity was 2.64 (median 1.03).

What is the liquidity of MEDI NORWAY AS like?

The current ratio was 1.34 in 2024 (median 1.62).

How does MEDI NORWAY AS compare in Handel?

MEDI NORWAY AS ranks 10,619 of 28,783 in Handel for 2024. Among companies of the same size (small companies) it ranks 9,981 of 27,072. Revenue changed by 14.8% from the year before.

Public contracts

Contracts awarded since 2024
2
Total awarded value since 2024
value not stated
1 contracts without a stated value are not in the total.
Framework agreements
1
Left out of the total: the value is a ceiling, not actual spend.
DateBuyerNotice ValueCPV
8 June 2026 SYKEHUSINNKJØP HF Utstyr til lymfødembehandling for helseforetakene i Norge 28.7 MNOK (framework) 33155000
10 December 2024 SYKEHUSINNKJØP HF Kontraktstildeling: Sårbehandlingsprodukter til sykehusene i Helse Midt-Norge value not stated 33140000

Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.

Source: Doffin (DFØ), fetched 27 October 2026. Winners are matched on organisation number.

Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0

From the Central Coordinating Register

Org. no.
968259733
Legal form
AS
Sector
Handel (46.460)
Size tier
small
Employees
17 registered 10 July 2026
Founded
15 December 1993 32 years in operation
Share capital
0.26 MNOK
Business address
Vestheimvegen 35, 4250 KOPERVIK (KARMØY)
Municipality
Karmøy rank 1–6 of 13 in KOSTRA group 10
Latest accounts filed
2025
Website
www.medinorway.no

Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre

Ownership and roles

Chief executive
Ragnhild Davidsen
Chair of the board
Gian Carlo Sciuchetti
Board member
Ragnhild Davidsen
Auditor
CEDRA NORGE AS
Accountant
ECIT FORRETNINGSPARTNER AS

Source: Central Coordinating Register, fetched 28 October 2026. Only names are shown.

Owners and shareholdings will appear here once the shareholder data extract is in place.

Coming · not built yet

Error in the data?

Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.

Report an issue

Figures last fetched 28 October 2026.

Details

Year by year · 2023–2025

Key figure202320242025Trend
Index625753
Rank7,71710,61913,445
Operating margin9.5%7.7%4.7%
Return on assets19.0%19.2%13.0%
Equity ratio40.2%27.4%32.2%
Current ratio1.611.341.43
Revenue growth–14.8%1.5%

Accounts

From the Brønnøysund Register Centre, in the company's reporting currency (NOK).

Key figure202320242025
Operating revenue47.9 MNOK55.0 MNOK55.8 MNOK
Operating profit4.5 MNOK4.2 MNOK2.6 MNOK
Profit before tax4.3 MNOK4.3 MNOK2.7 MNOK
Net profit3.4 MNOK3.3 MNOK2.1 MNOK
Financial expenses0.3 MNOK0.1 MNOK0.1 MNOK
Total assets24.2 MNOK22.8 MNOK21.3 MNOK
Current assets23.2 MNOK22.1 MNOK20.7 MNOK
Equity9.7 MNOK6.3 MNOK6.9 MNOK
Retained earnings9.5 MNOK6.0 MNOK6.6 MNOK
Total liabilities14.4 MNOK16.6 MNOK14.5 MNOK
Current liabilities14.4 MNOK16.5 MNOK14.4 MNOK

Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 28 October 2026, accounts id 6133997.

Similar companies